These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32187210)

  • 21. Opportunistic Risk Screening for Type 2 Diabetes: Exploring of Application of Diabetes Risk Assessment Tool in Community Pharmacy in Australia and Thailand.
    Thoopputra T; Pongmesa T; Newby DA; Schneider J; Li SC
    Value Health Reg Issues; 2016 May; 9():1-7. PubMed ID: 27881250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Mitchell B; Clarke P; Brillant M; Dienaar R; Hughes J; Lau P; Peterson G; Stewart K; Taylor S; Wilkinson J; Armour C
    Diabetes Res Clin Pract; 2007 Mar; 75(3):339-47. PubMed ID: 16884811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist.
    Dhippayom T; Fuangchan A; Tunpichart S; Chaiyakunapruk N
    J Public Health (Oxf); 2013 Jun; 35(2):262-9. PubMed ID: 22976588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
    Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
    Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for people with abnormal glucose metabolism in the European DE-PLAN project.
    Cos FX; Barengo NC; Costa B; Mundet-Tudurí X; Lindström J; Tuomilehto JO;
    Diabetes Res Clin Pract; 2015 Jul; 109(1):149-56. PubMed ID: 25931281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with a colorectal cancer campaign in Swiss pharmacies.
    Ruggli M; Stebler D; Gasteiger M; Trottmann M; Hochuli P; Telser H; Vaucher F
    Int J Clin Pharm; 2019 Oct; 41(5):1359-1364. PubMed ID: 31564044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies.
    Pappaccogli M; Ravetto Enri L; Perlo E; Di Monaco S; Pignata I; Baratta F; Rabbia F; Mana M; Veglio F; Brusa P
    Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1316-1322. PubMed ID: 31383504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk-stratified screening for diabetes in adults: results of the first investigation in Hungary].
    Winkler G; Hidvégi T; Vándorfi G; Jermendy G
    Orv Hetil; 2010 Apr; 151(17):691-6. PubMed ID: 20388612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
    Barengo NC; Tamayo DC; Tono T; Tuomilehto J
    Prim Care Diabetes; 2017 Feb; 11(1):86-93. PubMed ID: 27727004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular drug use prior to diagnosis of diabetes: a pilot study in community pharmacy.
    Simoens S; De Coster S; Dethier M; Lenie J; Meuwissen P; Laekeman G
    Int J Pharm Pract; 2009 Apr; 17(2):127-9. PubMed ID: 20214262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Two Relevant Diseases of the Endocrine System: Diabetes Mellitus and Thyroid Disorders.
    Dalla Zuanna T; Pitter G; Canova C; Simonato L; Gnavi R
    Epidemiol Prev; 2019; 43(4 Suppl 2):17-36. PubMed ID: 31650804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje.
    Shahim B; Hasselberg S; Boldt-Christmas O; Gyberg V; Mellbin L; Rydén L
    Eur J Prev Cardiol; 2018 Dec; 25(18):1990-1999. PubMed ID: 30289273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes screening in primary care: the PRE.DI.CO. study.
    Bonaccorsi G; Guarducci S; Ruffoli E; Lorini C
    Ann Ig; 2012; 24(6):527-34. PubMed ID: 23234190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irish diabetes detection programme in general practice.
    Smith SM; Holohan J; McAuliffe A; Firth RG
    Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
    Castillo D; Guayta R; Giner J; Burgos F; Capdevila C; Soriano JB; Barau M; Casan P;
    Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Making the invisible visible' through alcohol screening and brief intervention in community pharmacies: an Australian feasibility study.
    Hattingh HL; Hallett J; Tait RJ
    BMC Public Health; 2016 Nov; 16(1):1141. PubMed ID: 27825369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for type 2 diabetes and prediabetes--methodological concerns and feasibility in Hungary].
    Jermendy G; Hidvégi T; Vándorfi G; Winkler G
    Orv Hetil; 2010 Apr; 151(17):683-90. PubMed ID: 20388611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population.
    Štiglic G; Fijačko N; Stožer A; Sheikh A; Pajnkihar M
    Diabetes Res Clin Pract; 2016 Oct; 120():194-7. PubMed ID: 27592167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.